Going beyond bibliometrics: A system to track the progress and impact of biomedical research funded by Susan G. Komen.

Traditional metrics used to assess the outcomes and impact of biomedical research, such as publications, citations, and follow-up grant funding, do not measure the impact on changes in health practice (standard of care), policy, guidelines, or other societal outcomes and may not be meaningful to stakeholders, such as patients, donors, or the public. Susan G. Komen has developed a research product tracking system to monitor the progress of Komen-funded research products along the research pipeline and to measure the potential impact on patients more directly.

Metastasis-associated protein ribosomal RNA processing 1 homolog B (RRP1B) modulates metastasis through regulation of histone methylation.

Unlabelled: Overexpression of ribosomal RNA processing 1 homolog B (RRP1B) induces a transcriptional profile that accurately predicts patient outcome in breast cancer. However, the mechanism by which RRP1B modulates transcription is unclear. Here, the chromatin-binding properties of RRP1B were examined to define how it regulates metastasis-associated transcription.

Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma.

More than 3.5 million nonmelanoma skin cancers were treated in 2006; of these 700,000 were cutaneous squamous cell carcinomas (cSCCs). Despite clear environmental causes for cSCC, studies also suggest genetic risk factors.

Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer.

One of the most serious complications faced by patients with inflammatory bowel disease (IBD) is the potential development of colorectal cancer (CRC). There is a compelling need to enhance the accuracy of cancer screening of IBD patients. MicroRNAs (miRNAs) are small nonprotein-coding RNAs that play important roles in CRC oncogenesis.

Germline variation controls the architecture of somatic alterations in tumors.

Studies have suggested that somatic events in tumors can depend on an individual's constitutional genotype. We used squamous cell carcinomas (SCC) of the skin, which arise in high multiplicity in organ transplant recipients, as a model to compare the pattern of somatic alterations within and across individuals. Specifically, we performed array comparative genomic hybridization on 104 tumors from 25 unrelated individuals who each had three or more independently arisen SCCs and compared the profiles occurring within patients to profiles of tumors across a larger set of 135 patients.

Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals.

Squamous cell carcinoma (SCC) is the second most frequently diagnosed skin cancer. It has a higher incidence in immunosuppressed individuals such as organ transplant recipients and human immunodeficiency virus (HIV) carriers. Recently, a newly described polyoma virus, Merkel cell polyomavirus (MCPyV), was found in Merkel cell carcinoma (MCC), a rare aggressive skin cancer also associated with immunosuppression.

Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

Epigenetic alterations of the genome such as DNA promoter methylation and chromatin remodeling play an important role in tumorigenesis. Recent findings indicate epigenetic modifications as key factors in breast carcinogenesis. These modifications are quite appealing as targets for preventative care and therapeutics because of their potential for reversal.

Methylation not a frequent "second hit" in tumors with germline BRCA mutations.

Mutations in tumor suppressor genes BRCA1 and BRCA2 confer an increased lifetime risk of breast and ovarian cancer. Loss of heterozygosity (LOH) of the wildtype allele has been observed in approximately 80% of tumors from BRCA1 carriers and 70% of tumors from BRCA2 carriers and accounts for the majority of the "second-hits" occurring in BRCA-related tumors. Few sporadic tumors have been reported to have mutations in BRCA.

Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice.

In immunocompromised individuals, such as organ transplant recipients, the risk of cutaneous squamous cell carcinoma (SCC) is increased 60-250 fold, and there is an increased likelihood to develop aggressive, metastatic SCC. An understanding of the genes involved in SCC tumorigenesis is critical to prevent SCC-associated morbidity and mortality. Mouse models show that different immunosuppressive drugs lead to SCCs varying in size, number, and malignant potential.

Sequence divergence of Mus spretus and Mus musculus across a skin cancer susceptibility locus.

Background: Mus spretus diverged from Mus musculus over one million years ago. These mice are genetically and phenotypically divergent. Despite the value of utilizing M.

Y-aromaticity: why is the trimethylenemethane dication more stable than the butadienyl dication?

[reactions: see text] Resonance energies of the trimethylenemethane dication (1) and the butadienyl dication (4) were evaluated using two independent computational methodologies to provide insight into the validity of Y-aromaticity. One methodology employed density functional theory calculations and examined the resonance contribution of the C=C double bond toward the double hydride abstraction enthalpies of methylpropene (6) and 2-butene (8), yielding 1 and 4, respectively. These resonance contributions by the double bond were determined by calculating the double hydride abstraction enthalpies of both the parallel and perpendicular conformations of vinylogues of 6 and 8, in which n = 1-4 vinyl units were inserted between the central carbon-carbon double bond and each of the reaction centers.